Skip to main navigation Skip to search Skip to main content

Botulinum toxin in facial plastic surgery

  • SUNY Buffalo

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Since the U.S. Food and Drug Administration approved botulinum toxin (BoNT) type A in 2002 for glabellar rhytids, BoNT has been used successfully for many clinical indications in facial plastic surgery. The current usage of BoNT as a non-invasive procedure for rhytids of the aging face include but are not limited to rhytids of the forehead, glabella, lateral orbit, nasal sidewall, upper lip, vertical perioral rhytids, melomental fold, and chin. In addition to facial rhytids, BoNT has been shown to be effective for a variety of other clinical indications in facial plastic surgery, including masseter hypertrophy, facial paralysis, brow ptosis, and wound healing. This article will review the pharmacology and mechanism of action of BoNT. In addition, the suggested dosage and instruction for injection for facial rhytids will be discussed along with BoNT usage for clinical indications other than rhytids.

Original languageEnglish
JournalPlastic and Aesthetic Research
Volume7
DOIs
StatePublished - 2020

Keywords

  • botox
  • Botulinum toxin
  • neurotoxin

Fingerprint

Dive into the research topics of 'Botulinum toxin in facial plastic surgery'. Together they form a unique fingerprint.

Cite this